New strategy aims to tame cancer before risky treatment
NCT ID NCT04981912
Summary
This study is testing a new order for giving approved cancer drugs. The goal is to see if giving two drugs first can safely shrink the amount of cancer in the body. This could make it safer to start a third, powerful drug by lowering the risk of a dangerous side effect called tumor lysis syndrome. The study is for adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has come back or stopped responding to prior treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.